Jane Street’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
+124,822
| New | +$206K | ﹤0.01% | 4714 |
|
|
2025
Q1 | – | Sell |
-20,286
| Closed | -$68K | – | 6659 |
|
|
2024
Q4 | $68K | Buy |
+20,286
| New | +$68K | ﹤0.01% | 5430 |
|
|
2023
Q1 | – | Sell |
-1,026
| Closed | -$2.77K | – | 6274 |
|
|
2022
Q4 | $2.77K | Sell |
1,026
-1,787
| -64% | -$4.83K | ﹤0.01% | 5341 |
|
|
2022
Q3 | $11K | Buy |
+2,813
| New | +$11K | ﹤0.01% | 5423 |
|
|
2022
Q2 | – | Sell |
-672
| Closed | -$8K | – | 6345 |
|
|
2022
Q1 | $8K | Sell |
672
-735
| -52% | -$8.75K | ﹤0.01% | 5493 |
|
|
2021
Q4 | $26K | Buy |
+1,407
| New | +$26K | ﹤0.01% | 5038 |
|
|
2021
Q2 | – | Sell |
-935
| Closed | -$115K | – | 5824 |
|
|
2021
Q1 | $115K | Buy |
+935
| New | +$115K | ﹤0.01% | 4511 |
|
|
2020
Q4 | – | Sell |
-1,375
| Closed | -$164K | – | 4466 |
|
|
2020
Q3 | $164K | Buy |
1,375
+186
| +16% | +$22.2K | ﹤0.01% | 3304 |
|
|
2020
Q2 | $148K | Buy |
1,189
+503
| +73% | +$62.6K | ﹤0.01% | 3545 |
|
|
2020
Q1 | $132K | Buy |
+686
| New | +$132K | ﹤0.01% | 3021 |
|